Oral Dutasteride Is a First-Line Treatment for Frontal Fibrosing Alopecia

July 2024 in “ Journal of the European Academy of Dermatology and Venereology ”

Sergio Vañó‐Galván, David Saceda‐Corralo

dutasteride frontal fibrosing alopecia antifibrotic properties oestradiol immunomodulatory effects Avodart

Studysummary This review concludes that oral dutasteride has the highest evidence level for stabilizing frontal fibrosing alopecia and should be used as a first-line treatment until more randomized controlled trials are conducted.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

Oral dutasteride is recommended as a first-line treatment for frontal fibrosing alopecia (FFA) due to its effectiveness in stabilizing the condition, as demonstrated in a systematic review and meta-analysis involving 366 patients, where 62.8% achieved stabilization. Despite the lack of double-blind randomized controlled trials, dutasteride shows the highest level of evidence among available treatments. Its potential mechanisms include antifibrotic properties, increased tissue oestradiol levels, and immunomodulatory effects. The treatment is considered safe for off-label use and can be combined with other therapies if needed.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson's Disease Models

1 citations , July 2022 in “Frontiers in Pharmacology”

This study found that dutasteride may help prevent enteric neuronal damage in an animal model of Parkinson's disease, highlighting its potential for drug repurposing to address neuroinflammation.

research Genome-Wide Association Study in Frontal Fibrosing Alopecia Identifies Four Susceptibility Loci Including HLA-B*07:02

115 citations , March 2019 in “Nature Communications”

This study identified significant genetic associations with frontal fibrosing alopecia at four genomic loci, suggesting it is a genetically predisposed immuno-inflammatory disorder influenced by the HLA-B*07: 02 allele.

research Frontal Fibrosing Alopecia: A Multicenter Review of 355 Patients

339 citations , February 2014 in “Journal of The American Academy of Dermatology”

This study found that eyelash loss, facial papules, and body hair involvement were linked to severe frontal fibrosing alopecia, and antiandrogens were the most effective treatment.